Department of Otorhinolaryngology and Head and Neck Surgery, Radboud University Medical Centre, Nijmegen, the Netherlands.
Department of Oncology, Radboud University Medical Centre, Nijmegen, the Netherlands.
Otolaryngol Head Neck Surg. 2020 Apr;162(4):446-457. doi: 10.1177/0194599820906387. Epub 2020 Feb 25.
An increased interval between symptomatic disease and treatment may negatively influence oncologic and/or functional outcomes in head and neck cancer (HNC). This systematic review aims to provide insight into the effects of time to treatment intervals on oncologic and functional outcomes in oral cavity, pharyngeal, and laryngeal cancer.
PubMed, EMBASE, and Cochrane library were searched.
All studies on delay or time to diagnosis or treatment in oral, pharyngeal, and laryngeal cancer were included. Quality assessment was performed with an adjusted version of the Newcastle-Ottawa scale. Outcomes of interest were tumor volume, stage, recurrence, survival, patient-reported outcome measures (PROMs), toxicity, and functionality after treatment.
A total of 51 studies were included. Current literature on the influence of delay in HNC is inconsistent but indicates higher stage and worse survival with longer delay. The effects on PROMs, toxicity, and functional outcome after treatment have not been investigated. The inconsistencies in outcomes were most likely caused by factors such as heterogeneity in study design, differences in the definitions of delay, bias of results, and incomplete adjustment for confounding factors in the included studies.
Irrespective of the level of evidence, the unfavorable effects of delay on oncologic, functional, and psychosocial outcomes are undisputed. Timely treatment while maintaining high-quality diagnostic procedures and decision making reflects good clinical practice in our opinion. This review will pose practical and logistic challenges that will have to be overcome.
症状出现与治疗之间的时间间隔增加可能会对头颈部癌症(HNC)的肿瘤学和/或功能结果产生负面影响。本系统评价旨在深入了解口腔、咽和喉癌的治疗时间间隔对肿瘤学和功能结果的影响。
对 PubMed、EMBASE 和 Cochrane 图书馆进行了检索。
纳入所有关于口腔、咽和喉癌诊断或治疗延迟或时间的研究。使用纽卡斯尔-渥太华量表的调整版本进行质量评估。感兴趣的结果包括肿瘤体积、分期、复发、生存、患者报告的结果测量(PROMs)、毒性和治疗后的功能。
共纳入 51 项研究。目前关于 HNC 延迟影响的文献不一致,但表明延迟时间越长,分期越高,生存率越低。对 PROMs、毒性和治疗后功能结果的影响尚未得到调查。结果的不一致性很可能是由于研究设计的异质性、延迟定义的差异、结果的偏倚以及纳入研究中混杂因素调整不完整等因素造成的。
无论证据水平如何,延迟对肿瘤学、功能和社会心理结果的不利影响是无可争议的。在我们看来,及时治疗同时保持高质量的诊断程序和决策反映了良好的临床实践。本综述将提出实际和后勤方面的挑战,这些挑战必须加以克服。